TCL Archive ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk August 2, 1991
TCL Archive The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff. October 21, 2005
